Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saima Hassan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Surgical Oncology|November 5, 2014
Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit diseaseSaima Hassan, Teresa M Petrella, Tong Zhang, et al.
The Oncologist|July 13, 2022
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in QuebecSaima Hassan, Rami Younan, Erica Patocskai, et al.
Cancer Research|August 23, 2015
The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast CancersStéphanie Légaré, Luca Cavallone, Aline Mamo, et al.
Scientific Reports|September 8, 2020
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancerLuca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Breast Cancer Research and Treatment|March 22, 2023
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41Priya Rastogi, Gong Tang, Saima Hassan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapyMélissa Viens, Karen Geoffroy, Elline Meuriot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2016
Cross-linguistic patterns in the acquisition of quantifiersNapoleon Katsos, Chris Cummins, Maria-José Ezeizabarrena, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|December 10, 2025
2025 Canadian Surgery Forum: Sept. 17-20, 2025Bailey Russell, Donna Stewart, Karen Devon, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Surgical Oncology|November 5, 2014
Pathologic complete response to intralesional interleukin-2 therapy associated with improved survival in melanoma patients with in-transit diseaseSaima Hassan, Teresa M Petrella, Tong Zhang, et al.
The Oncologist|July 13, 2022
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in QuebecSaima Hassan, Rami Younan, Erica Patocskai, et al.
Cancer Research|August 23, 2015
The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast CancersStéphanie Légaré, Luca Cavallone, Aline Mamo, et al.
Scientific Reports|September 8, 2020
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancerLuca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Breast Cancer Research and Treatment|March 22, 2023
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41Priya Rastogi, Gong Tang, Saima Hassan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapyMélissa Viens, Karen Geoffroy, Elline Meuriot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2016
Cross-linguistic patterns in the acquisition of quantifiersNapoleon Katsos, Chris Cummins, Maria-José Ezeizabarrena, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|December 10, 2025
2025 Canadian Surgery Forum: Sept. 17-20, 2025Bailey Russell, Donna Stewart, Karen Devon, et al.
Pageof 3